Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection

por Schmidt, Katja G., Harrer, Ellen G., Tascilar, Koray, Kübel, Sabrina, El Kenz, Boutaina, Hartmann, Fabian, Simon, David, Schett, Georg, Nganou-Makamdop, Krystelle, Harrer, Thomas
Publicado 2022

Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine

por Schmidt, Katja G., Harrer, Ellen G., Schönau, Verena, Simon, David, Kleyer, Arnd, Steininger, Philipp, Korn, Klaus, Schett, Georg, Knobloch, Carina S., Nganou-Makamdop, Krystelle, Harrer, Thomas
Publicado 2023

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses

por Schmidt, Katja G., Nganou-Makamdop, Krystelle, Tenbusch, Matthias, El Kenz, Boutaina, Maier, Clara, Lapuente, Dennis, Überla, Klaus, Spriewald, Bernd, Bergmann, Silke, Harrer, Ellen G., Harrer, Thomas
Publicado 2021

Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller

por El Kenz, Boutaina, Schmidt, Katja G., Ogungbemi-Alt, Victoria K., Bergmann, Silke, Steininger, Philipp, Korn, Klaus, Spriewald, Bernd, Harrer, Ellen G., Nganou-Makamdop, Krystelle, Harrer, Thomas
Publicado 2023